Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8 T-cell response compared with cyclosporine- or mycophenolate-treated patients (Q45140581)
Jump to navigation
Jump to search
scientific article published in January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8 T-cell response compared with cyclosporine- or mycophenolate-treated patients |
scientific article published in January 2013 |
Statements
1 reference
Everolimus-treated renal transplant recipients have a more robust CMV-specific CD8 T-cell response compared with cyclosporine- or mycophenolate-treated patients (English)
1 reference
1 reference
Simone H C Havenith
1 reference
Si La Yong
1 reference
Karlijn A M I van Donselaar-van der Pant
1 reference
Ineke J M ten Berge
1 reference
Fréderike J Bemelman
1 reference
1 January 2013
1 reference
1 reference
95
1 reference
1
1 reference
184-191
1 reference
Identifiers
1 reference
1 reference